CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Sales: | ||||
| Total Sales | $ 2,180,007 | $ 3,426,823 | $ 11,062,203 | $ 8,937,633 |
| Cost of Sales: | ||||
| Cost of Sales - Depreciation and Amortization | 232,891 | 221,772 | 723,745 | 676,720 |
| Total Cost of Sales | 2,417,551 | 2,558,602 | 9,451,356 | 7,328,335 |
| Gross Profit (Loss) | (237,544) | 868,221 | 1,610,847 | 1,609,298 |
| Operating Expenses: | ||||
| Research and Development | 2,912,562 | 3,440,685 | 8,818,911 | 9,540,272 |
| Selling and Marketing | 2,832,031 | 1,980,748 | 7,881,612 | 5,895,332 |
| General and Administrative | 4,466,850 | 4,854,014 | 13,858,996 | 15,307,242 |
| Depreciation and Amortization | 959,353 | 510,099 | 2,896,840 | 1,149,046 |
| Impairment of Patents and Trademarks | 24,204 | 48,075 | 41,869 | 97,676 |
| Total Operating Expenses | 11,195,000 | 10,833,621 | 33,498,228 | 31,989,568 |
| Loss From Operations | (11,432,544) | (9,965,400) | (31,887,381) | (30,380,270) |
| Other Income (Expense): | ||||
| Investment Income | 500,067 | 572,721 | 1,824,773 | 690,028 |
| Income and Other Taxes | (21,715) | (19,768) | (144,930) | (98,727) |
| Foreign Exchange Loss | (28,816) | (64,552) | (60,973) | (215,698) |
| Total Other Income, Net | 449,536 | 488,401 | 1,618,870 | 375,603 |
| Loss Before Provision for Income Taxes | (10,983,008) | (9,476,999) | (30,268,511) | (30,004,667) |
| Net Loss | $ (10,983,008) | $ (9,476,999) | $ (30,268,511) | $ (30,004,667) |
| Basic Loss per Common Share | $ (0.17) | $ (0.15) | $ (0.48) | $ (0.47) |
| Diluted Loss per Common Share | $ (0.17) | $ (0.15) | $ (0.48) | $ (0.47) |
| Weighted-average Shares Outstanding - Basic | 63,324,942 | 63,776,154 | 63,257,863 | 63,724,982 |
| Weighted-average Shares Outstanding - Diluted | 63,324,942 | 63,776,154 | 63,257,863 | 63,724,982 |
| Sales of Products | ||||
| Sales: | ||||
| Total Sales | $ 1,371,851 | $ 2,537,539 | $ 9,988,374 | $ 7,939,483 |
| Cost of Sales: | ||||
| Cost of Sales | 1,884,239 | 2,034,123 | 8,270,658 | 6,289,612 |
| Sales of Engineering Services | ||||
| Sales: | ||||
| Total Sales | 808,156 | 889,284 | 1,073,829 | 998,150 |
| Cost of Sales: | ||||
| Cost of Sales | $ 300,421 | $ 302,707 | $ 456,953 | $ 362,003 |
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount income and other taxes expenses (benefit). No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|